Ciaffoni Joseph 4
4 · Indivior Pharmaceuticals, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Indivior (INDV) CEO Joseph Ciaffoni Receives RSU Award
What Happened
- Joseph Ciaffoni, Chief Executive Officer of Indivior Pharmaceuticals (INDV), received a grant of 79,976 restricted stock units (RSUs) on February 10, 2026. The RSUs were granted at $0.00 (no cash paid) and represent a contingent right to receive shares if vesting conditions are met. This is an award/grant (transaction code A), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-02-10; Filing date: 2026-02-12 (timely within the Form 4 two-business-day rule).
- Amount: 79,976 RSUs granted; reported acquisition price: $0.00 (grant).
- Vesting: RSUs vest in three equal annual installments beginning Feb 10, 2027, subject to continued service (see footnote F1).
- Shares owned after the transaction: Not specified in the filing.
- Footnotes/Exhibits: F1 describes RSU vesting schedule; Exhibit 24 is a Power of Attorney. No tax-withholding or sale-on-vesting details were disclosed in this filing.
Context
- RSU grants are a form of equity compensation that convert to ordinary shares only when they vest; they do not represent immediately tradable shares. Such awards are common for executive compensation and do not necessarily signal a near-term buy or sell by the insider.
Insider Transaction Report
Form 4
Ciaffoni Joseph
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-02-10+79,976→ 135,976 total
Footnotes (1)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
Signature
/s/Alice Givens, Power of Attorney|2026-02-12